Funding for this research was provided by:
Canadian Institutes of Health Research (152882)
Received: 1 October 2021
Accepted: 8 February 2022
First Online: 16 March 2022
: Ethics approval for the GN-CHA was obtained from the Manitoulin Anishinaabek Research Review Committee (MARRC), who issued an Ethics Certificate on September 1, 2016. Informed consent forms were signed by all participants. Consent included survey participation and the linking of the information from the GN-CHA to data obtained from previous surveillance programs and/or studies of Hg exposure. Ethics approval for the present study was obtained from the <i>Université du Québec à Montréal</i> (2016_e_1350) and Health Canada Research Ethics Board (REB 2017–0006).
: All participants provided consent for publication. The present study was presented to Grassy Narrows’ Chief and Council of, who approved the manuscript for publication on May 12, 2021.
: The authors declare that they have no competing interests.